Shorena Vashadze


Every year about 6 million people in the world have a stroke. Our purpose is to study cases of brain blood circulation disorders in order to determine functional activity of leukocytes of the peripheral blood in patients with chronic ischemia and brain infarction. To carry out the comparative analysis of indicators of functional activity of leukocytes of blood with the clinical picture of a disease and indicators of the hemostasis system.

100 persons (60 men and 40 women at the age of 18 and older) who had a stroke within 1-3 weeks were examined. Tomography (MRI) in the examination of brain of primary patients with the clinical diagnosis of a stroke has been conducted. Sharp brain blood circulation disorder was confirmed by means of MRI at 35 of 100 patients. Examination of 31 patients’ brain was conducted between 3 and 12 hours after the beginning of the disease. The comparison group was made of 30 healthy persons (30%). In a group of patients with the chronic cerebral ischemia (CCI) there is an increase in quantity of leukocytes (by 1.3 times). In a group of patients with an ischemic stroke insignificant decrease in quantity of leukocytes with activated chromatin below the control indicators is noted. Degranulation of leukocytes takes place, as well as the emission of the lysosomal enzymes into the pericellular space. This confirms the participation of cells of a lymphoid line of peripheral blood in sharp cerebral ischemia. Distinct correlation between functional activity of blood leukocytes and a clinical picture of a disease and hemostasis system indicators was revealed. This can serve as a method of differential diagnostics of patients with chronic ischemia and brain infarction, as well as an objective way of controlling the efficiency.

Full Text:



Insul't: diagnostika, lechenie, profilaktika. [Stroke: diagnostics, treatment, prevention]., Edited by. Z.A. Suslinoi, M.A. Piradova. - Moskva., MEDpress–inform, 2008.

Kornienko V.N., Pronin I.N., P'yanykh I.S., Fadeeva L.M. Issledovanie tkanevoi perfuzii golovnogo mozga metodom komp'yuternoi tomografii. Meditsinskaya vizualizatsiya [The study of brain tissue perfusion by computed tomography method. Medical visualization]., 2007, No. 2., pp. 70–81.

Adams H.P., del Zoppo G., Alberts M.J. et al. Guidelines for the Early Management of Adults WithIschemic–Stroke. - Stroke., 2007; 38:1655–1711


Hacke W., Albers G., Al–Rawi Y. et al. The Desmoteplase in Acute Stroke Trial (DIAS): A Phase II MRIBased 9–hour Window Acute Stroke Thrombolysis Trial with Intravenous Desmoteplase. – Stroke., 2005; 36:66–73.


Michel P., Reichhart M., Schindler C., Bogousslavsky J., Meuli R., Wintermark M. CT–perfusion guided intravenous thrombolysis for unknown onset of stroke symptoms: clinical results of a pilot study. International Journal of Stroke, 2008; Volume 3, Issue s1 (Abstracts of the 6th World Stroke Congress and Xth International Symposium on Thrombolysis and Acute Stroke Therapy, 24–27 September 2008., Vienna, Austria and 21–23 September 2008, Budapest, Hungary)., p. 271.

Miles K.A., Eastwood J.D., Konig M. (eds). Multidetector Computed Tomography in Cerebrovascular Disease. CT Perfusion Imaging. Informa UK, 2007.

Parsons M.W.. Perfusion C.T.: is it clinically useful? International Journal of Stroke., Vol. 3., February. 2008., pp. 41–50.


Roccatagliata L., Lev M.H., Mehta N., Koroshetz W.J., Gonzalez R.G., Schaefer P.W. (2003) Estimating the size of ischemic regions on CT perfusion maps in acute stroke: is freehand visual segmentation sufficient? Proceedings of the 89th Scientific Assembly and Annual Meeting of the Radiological Society of North America. – Chicago., IL., 2003., p. 1292

Shetty S.H., Lev M.H. CT perfusion. In: Gonzalez R.G., Hirsch J.A., Koroshetz W.J .et al (eds) Acute Ischemic Stroke. Imaging and Intervention. Springer–Verlag Berlin Heidelberg, 2006.

The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008



  • There are currently no refbacks.

Creative Commons License
GISAP: Medical Science, Pharmacology is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at
Permissions beyond the scope of this license may be available at